XML 11 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Related Party [Member]
Common Stock [Member]
Common Stock [Member]
Related Party [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Related Party [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning Balance, Values at Dec. 31, 2022 $ 231,194   $ 48   $ 669,780   $ (372) $ (438,262)
Beginning Balance, Shares at Dec. 31, 2022     47,722,995          
Exercise of stock options 111       111      
Exercise of stock options, Shares     55,605          
Exercise of pre-funded warrants, Value     $ 3   (3)      
Exercise of pre-funded warrants, Shares     2,582,557          
Issuance of common stock, net of issuance costs, Value   $ 17,470   $ 2   $ 17,468    
Issuance of common stock, net of issuance costs, Shares       2,646,458        
Restricted stock vested in the period     73,058          
Stock-based compensation 4,607       4,607      
Other comprehensive income (loss) 155           155  
Net loss (38,676)             (38,676)
Ending Balance, Values at Mar. 31, 2023 214,861   $ 53   691,963   (217) (476,938)
Ending Balance, Shares at Mar. 31, 2023     53,080,673          
Beginning Balance, Values at Dec. 31, 2022 231,194   $ 48   669,780   (372) (438,262)
Beginning Balance, Shares at Dec. 31, 2022     47,722,995          
Net loss (106,346)              
Ending Balance, Values at Sep. 30, 2023 156,839   $ 53   701,517   (123) (544,608)
Ending Balance, Shares at Sep. 30, 2023     53,238,985          
Beginning Balance, Values at Mar. 31, 2023 214,861   $ 53   691,963   (217) (476,938)
Beginning Balance, Shares at Mar. 31, 2023     53,080,673          
Exercise of stock options, Shares     283          
Issuance of common stock per Employee Stock Purchase Plan purchase , Shares     70,155          
Issuance of common stock per Employee Stock Purchase Plan purchase , Value 345       345      
Stock-based compensation 4,660       4,660      
Other comprehensive income (loss) 46           46  
Net loss (35,188)             (35,188)
Ending Balance, Values at Jun. 30, 2023 184,724   $ 53   696,968   (171) (512,126)
Ending Balance, Shares at Jun. 30, 2023     53,151,111          
Restricted stock vested in the period     87,874          
Stock-based compensation 4,549       4,549      
Other comprehensive income (loss) 48           48  
Net loss (32,482)             (32,482)
Ending Balance, Values at Sep. 30, 2023 156,839   $ 53   701,517   (123) (544,608)
Ending Balance, Shares at Sep. 30, 2023     53,238,985          
Beginning Balance, Values at Dec. 31, 2023 250,556   $ 78   823,029   (52) (572,499)
Beginning Balance, Shares at Dec. 31, 2023     78,369,099          
Exercise of stock options 217       217      
Exercise of stock options, Shares     105,526          
Exercise of pre-funded warrants, Value     $ 5   (5)      
Exercise of pre-funded warrants, Shares     5,243,400          
Issuance of common stock, net of issuance costs, Value 32,198   $ 7   32,191      
Issuance of common stock, net of issuance costs, Shares     6,639,348          
Restricted stock vested in the period     124,695          
Stock-based compensation 4,660       4,660      
Other comprehensive income (loss) (50)           (50)  
Net loss (25,176)             (25,176)
Ending Balance, Values at Mar. 31, 2024 262,405   $ 90   860,092   (102) (597,675)
Ending Balance, Shares at Mar. 31, 2024     90,482,068          
Beginning Balance, Values at Dec. 31, 2023 $ 250,556   $ 78   823,029   (52) (572,499)
Beginning Balance, Shares at Dec. 31, 2023     78,369,099          
Exercise of stock options, Shares 248,907              
Net loss $ (89,610)              
Ending Balance, Values at Sep. 30, 2024 331,560   $ 106   993,486   77 (662,109)
Ending Balance, Shares at Sep. 30, 2024     105,710,290          
Beginning Balance, Values at Mar. 31, 2024 262,405   $ 90   860,092   (102) (597,675)
Beginning Balance, Shares at Mar. 31, 2024     90,482,068          
Exercise of stock options 171       171      
Exercise of stock options, Shares     35,914          
Exercise of pre-funded warrants, Value     $ 1   (1)      
Exercise of pre-funded warrants, Shares     965,427          
Exercise of common warrants , Shares     19,901          
Issuance of common stock, net of issuance costs, Value 6,126   $ 1   6,125      
Issuance of common stock per Employee Stock Purchase Plan purchase , Shares     98,534          
Issuance of common stock and pre-funded warrants, net of issuance costs of $8,183, Value 116,817   $ 13   116,804      
Issuance of common stock and pre-funded warrants, net of issuance costs of $8,183, Shares     13,001,120          
Issuance of common stock, net of issuance costs, Shares     936,719          
Issuance of common stock per Employee Stock Purchase Plan purchase , Value 215   $ 1   214      
Stock-based compensation 4,942       4,942      
Other comprehensive income (loss) 13           13  
Net loss (29,610)             (29,610)
Ending Balance, Values at Jun. 30, 2024 361,079   $ 106   988,347   (89) (627,285)
Ending Balance, Shares at Jun. 30, 2024     105,539,683          
Exercise of stock options 530       530      
Exercise of stock options, Shares     107,467          
Restricted stock vested in the period     63,140          
Stock-based compensation 4,609       4,609      
Other comprehensive income (loss) 166           166  
Net loss (34,824)             (34,824)
Ending Balance, Values at Sep. 30, 2024 $ 331,560   $ 106   $ 993,486   $ 77 $ (662,109)
Ending Balance, Shares at Sep. 30, 2024     105,710,290